Hepion Pharmaceuticals, Inc. (HEPA) has 22 open-market insider trades by 10 insiders since 2020. Over the last six months insiders net bought $1.2M. The most active filer is Robert T. Foster, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Vincent S. LoPriore | Chairman | — | 2 | $750K | 2026-09-03 |
| Gary S. Stetz | CEO | — | 3 | $175K | 2026-08-03 |
| Michael J. Purcell | Dir | — | 2 | $150K | 2026-08-03 |
| Sireesh Appajosyula | COO | — | 2 | $150K | 2026-08-03 |
| Robert T. Foster | Dir | — | 4 | $97K | 2023-09-18 |
| Peter Wijngaard | Dir | — | 4 | $92K | 2023-11-27 |
| John T. Cavan | CFO | — | 2 | $27K | 2021-02-18 |
| Gary S. Jacob | Dir | — | 1 | $20K | 2020-12-01 |
| John P. Brancaccio | Dir | — | 1 | $11K | 2020-12-02 |
| Danina Fisher | Dir | — | 1 | $10K | 2026-09-29 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Danina Fisher | Director | Buy | $10K | 2026-09-29 |
| Gary S. Stetz | CEO | Buy | $100K | 2026-08-03 |
| Gary S. Stetz | Director | Buy | $25K | 2026-08-03 |
| Vincent S. LoPriore | Chairman | Buy | $500K | 2026-08-03 |
| Michael J. Purcell | Director | Buy | $50K | 2026-04-21 |
| Vincent S. LoPriore | Chairman & 10% Owner | Buy | $250K | 2026-04-21 |
Companies that share insiders with HEPA, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Peter Wijngaard | Director | Buy | $15K | 2023-11-24 |
| Robert T. Foster | Director | Buy | $9K | 2023-09-18 |
| Robert T. Foster | CEO & Director | Buy | $9K | 2023-09-15 |
| Peter Wijngaard | Director | Buy | $17K | 2023-09-15 |
| John T. Cavan | CFO | Buy | $20K | 2021-02-18 |
| Robert T. Foster | Director | Buy | $40K | 2021-02-18 |
| Peter Wijngaard | Director | Buy | $22K | 2021-02-16 |
| Peter Wijngaard | Director | Buy | $38K | 2020-12-18 |
| Robert T. Foster | Director | Buy | $40K | 2020-12-08 |